calendar
5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
Sponsor: Hangzhou Endonom Medtech Co., Ltd.. Phase: NA. Conditions: Aortic Arch Aneurysm
Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: EARLY_PHASE1. Conditions: Gaucher Disease
Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Prostate Cancer
Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Renal Impairment
Sponsor: Gali Perel. Phase: NA. Conditions: Cancer, Sarcopenia, Muscle Mass Loss
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: High Altitude, Hypobaric Hypoxia, Risk Reduction
Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Eustachian Tube Dysfunction
Sponsor: Korea Institute of Radiological & Medical Sciences. Phase: . Conditions: Occupational Exposure to Radiation, Neoplasms, Radiation-Induced, Leukemia, Radiation-Induced, Radiation Effects
Sponsor: University of Gaziantep. Phase: NA. Conditions: Postoperative Pain
Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Rectal Cancer
Sponsor: ISIS Diabete Service. Phase: . Conditions: Diabetes Mellitus Type 1, Glucose Metabolism Disorder, Glycemic Control for Diabetes Mellitus, Fear of Hypoglycemia, Treatment Satisfaction, Quality of Life, Hypoglycaemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: . Conditions: Prostate Cancer
Sponsor: Xijing Hospital of Digestive Diseases. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis
Sponsor: University of Santiago de Compostela. Phase: NA. Conditions: Gingival Irritation
Sponsor: BioGaia AB. Phase: NA. Conditions: C-Section
Sponsor: Aldeyra Therapeutics, Inc.. Phase: PHASE3. Conditions: Allergic Conjunctivitis
Sponsor: National Hepatology & Tropical Medicine Research Institute. Phase: PHASE3. Conditions: Hepatitis C, Chronic, Hepatocellular Carcinoma
Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Parkinson Disease
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants
Sponsor: eleva GmbH. Phase: PHASE1. Conditions: C3 Glomerulopathy (C3G), Healthy Adult Participants
Sponsor: Centre Hospitalier Universitaire de Nice. Phase: . Conditions: Sleep
Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations
Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: KRAS Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Sponsor: Henrique Tedesco. Phase: NA. Conditions: Cold Therapy
Sponsor: Assistance Publique Hopitaux De Marseille. Phase: NA. Conditions: FOOD ALLERGY
Sponsor: IRCCS Fondazione Stella Maris. Phase: . Conditions: Hereditary Spastic Paraplegia
Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder
Sponsor: Ankara City Hospital Bilkent. Phase: NA. Conditions: Migraine, Central Sensitization
Sponsor: Centre Leon Berard. Phase: NA. Conditions: Cancer, Emergencies
Sponsor: Children's Hospital of Fudan University. Phase: PHASE4. Conditions: Crohn Disease, Infliximab, Immunosuppression, Children, Only
Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia
Sponsor: Nanopath, Inc. Phase: . Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, Vaginitis, Vaginal Diseases, Genital Diseases, Female, Female Urogenital Diseases, Urogenital Disease, Candidiasis, Mycoses, Vulvovaginitis, Vulvar Diseases, Vaginosis, Bacterial
Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Elderly, Antibiotics Overuse, Viral Infections, PCR Multiplex
Sponsor: University College, London. Phase: PHASE3. Conditions: Parkinson's Disease
Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: RADICULAR PAIN
Sponsor: Artvin Coruh University. Phase: NA. Conditions: Breast Cancer
Sponsor: University of Oklahoma. Phase: NA. Conditions: Cognition, Neurovascular Coupling Mechanism and Cognitive Function, Neurovascular Control, Brain Aging, Brain Activity
Sponsor: University of Oxford. Phase: NA. Conditions: Spinal Muscular Atrophy (SMA)
Sponsor: Roswell Park Cancer Institute. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma
Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Cervical Spinal Cord Injury, Tetraparesis, Tetraplegia
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE2. Conditions: EGFR-mutant Non-small Cell Lung Cancer, Potentially Resectable
Sponsor: Daiichi Sankyo Co., Ltd.. Phase: PHASE2. Conditions: Tenosynovial Giant Cell Tumor
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Sepsis and Septic Shock
Sponsor: University Medical Centre Ljubljana. Phase: . Conditions: Fontan Circulation, Fontan Procedure
Sponsor: Johns Hopkins University. Phase: . Conditions: Stroke, Stroke Sequelae, Stroke/Brain Attack
Sponsor: China National Center for Cardiovascular Diseases. Phase: . Conditions: Cardiomyopathies, Cost
Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Septic Shock
Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Melasma
Sponsor: University of South Dakota. Phase: NA. Conditions: Depression, Anxiety
Sponsor: Rutgers, The State University of New Jersey. Phase: PHASE2. Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Neoplasm, Metastatic Malignant Solid Neoplasm, POLD1 Gene Mutation, POLE Gene Mutation, Recurrent Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Stage III Breast Cancer AJCC v7, Stage III Ovarian Cancer AJCC v8, Stage IIIA Breast Cancer AJCC v7, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIB Breast Cancer AJCC v7, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Breast Cancer AJCC v7, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8